Search results for "Cardiovascular Disease"
Fasting may not be necessary before lipids testing, study finds
In this post hoc follow-up analysis of a randomized clinical trial, triglyceride levels were slightly higher in nonfasting samples than fasting samples, and cholesterol levels in both types of samples were similar.
https://immattersacp.org/weekly/archives/2019/06/04/4.htm
4 Jun 2019
AHA releases scientific statement on cardiovascular health in African-American patients
Obesity, hypertension, and diabetes generally occur earlier in African-American patients than in white patients, and adverse health behaviors may partly explain the higher burden of risk factors for cardiovascular disease.
https://immattersacp.org/weekly/archives/2017/10/31/4.htm
31 Oct 2017
Combined use of ED drugs, nitrates linked with worse outcomes in patients with CAD
Risks of myocardial infarction, heart failure, and mortality were significantly higher in coronary artery disease (CAD) patients taking nitrates and phosphodiesterase-5 inhibitors for erectile dysfunction (ED) than in patients taking nitrates alone.
https://immattersacp.org/weekly/archives/2024/01/16/2.htm
16 Jan 2024
MKSAP Quiz: Routine office visit for patient with HIV
A 44-year-old man is evaluated in the office during a routine visit. Medical history is significant for HIV diagnosed at age 25 years, hypertension, and hyperlipidemia. He is a current smoker. Following a physical exam, lab tests, and electrocardiogram, what factors will result in underestimation of the risk for atherosclerotic cardiovascular disease in this patient?
https://immattersacp.org/weekly/archives/2018/12/18/3.htm
18 Dec 2018
Statins often not prescribed in younger patients with dyslipidemia, study finds
Patients who had at least one indication for statin therapy were analyzed according to the following groups: LDL cholesterol level of at least 190 mg/dL, diabetes and LDL cholesterol level above 70 mg/dL, and atherosclerotic cardiovascular disease.
https://immattersacp.org/weekly/archives/2017/01/10/2.htm
10 Jan 2017
New assessment tool may improve predictions of CV risk, impact of preventive treatments
The new three-step tool aims to provide a framework for delivering appropriate risk-reducing strategies to Medicare patients with a 10-year atherosclerotic cardiovascular disease risk greater than 30%.
https://immattersacp.org/weekly/archives/2016/11/08/4.htm
8 Nov 2016
Guidance issued on nonstatin therapies for cholesterol lowering
The goal of the decision pathway was to provide practical guidance for clinicians and patients in situations not covered by the 2013 ACC/AHA guideline until new clinical guidelines on the topic are published.
https://immattersacp.org/weekly/archives/2016/04/05/4.htm
5 Apr 2016
Why internists should care about lipoprotein(a)
Lipoprotein(a) can be a significant risk factor for heart disease and requires consideration when developing a plan of care, especially in the highest risk patients.
https://immattersacp.org/archives/2020/05/why-internists-should-care-about-lipoproteina.htm
1 May 2020
Pearls for lowering lipids
New guidelines recommend basing treatment decisions on levels of risk rather than LDL targets.
https://immattersacp.org/archives/2016/07/lipids.htm
1 Jul 2016
Expert panel recommends SGLT2 inhibitor or GLP-1 receptor agonist for patients with type 2 diabetes and CVD
The American College of Cardiology's new decision pathway also calls for repeated HbA1c screening and detailed clinician-patient risk discussions for patients with cardiovascular disease (CVD) who are diagnosed with type 2 diabetes.
https://immattersacp.org/weekly/archives/2018/12/04/2.htm
4 Dec 2018